FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385330511> ?p ?o ?g. }

• W4385330511 abstract "Malignant ascites is prevalent in advanced-stage ovarian cancer and may facilitate identification of the drivers of muscle loss. This study aimed to evaluate the association of ascites with changes in systemic inflammation and muscle after treatment of advanced-stage ovarian cancer.We evaluated 307 patients with advanced-stage (III/IVA) ovarian cancer who underwent primary debulking surgery and adjuvant platinum-based chemotherapy between 2010 and 2019. The changes in skeletal muscle index (SMI) and radiodensity (SMD) were measured using pre-surgery and post-chemotherapy portal-venous phase contrast-enhanced computed tomography scans at L3. Systemic inflammation was measured using albumin levels, prognostic nutritional index (PNI), neutrophil-lymphocyte ratio (NLR), and platelet-lymphocyte ratio (PLR). Primary endpoint was the changes in SMI and SMD after treatment. Linear regression analysis was used to test associations between muscle change and other covariates. Mediation analysis was used to determine the mediator.The median (range) age was 53 (23-83) years. The median duration (range) of follow-up was 5.2 (1.1-11.3) years. Overall, 187 (60.9%) patients had ascites. The changes in muscle and systemic inflammatory markers after treatment were significantly different between patients with and without ascites (SMI: -3.9% vs. 2.2%, P < 0.001; SMD: -4.0% vs. -0.4%, P < 0.001; albumin: -4.4% vs. 2.1%, P < 0.001; PNI: -8.4% vs. -0.1%, P < 0.001; NLR: 20.6% vs. -29.4%, P < 0.001; and PLR: 1.7% vs. -19.4%, P < 0.001). The changes in SMI and SMD were correlated with the changes in albumin, PNI, NLR, and PLR (all P < 0.001). In multiple linear regression, ascites and NLR changes were negatively while albumin change was positively correlated with SMI change (ascites: β = -3.19, P < 0.001; NLR change: β = -0.02, P = 0.003; albumin change: β = 0.37, P < 0.001). Ascites and NLR changes were negatively while PNI change was positively correlated with SMD change (ascites: β = -1.28, P = 0.02; NLR change: β = -0.02, P < 0.001; PNI change: β = 0.11, P = 0.04). In mediation analysis, ascites had a direct effect on SMI change (P < 0.001) and an indirect effect mediated by NLR change (indirect effects = -1.61, 95% confidence interval [CI]: -2.22 to -1.08) and albumin change (indirect effects = -2.92, 95% CI: -4.01 to -1.94). Ascites had a direct effect on SMD change (P < 0.001) and an indirect effect mediated by NLR change (indirect effects = -1.76, 95% CI: -2.34 to -1.22) and PNI change (indirect effects = -2.00, 95% CI: -2.79 to -1.36).Malignant ascites was associated with enhanced systemic inflammation and muscle loss after primary debulking surgery and adjuvant chemotherapy in advanced-stage ovarian cancer. The association between ascites and muscle loss may be mediated by systemic inflammation." @default.
• W4385330511 created "2023-07-29" @default.
• W4385330511 creator A5005935812 @default.
• W4385330511 creator A5006613898 @default.
• W4385330511 creator A5008775517 @default.
• W4385330511 creator A5013682306 @default.
• W4385330511 creator A5037997481 @default.
• W4385330511 creator A5082840873 @default.
• W4385330511 date "2023-07-28" @default.
• W4385330511 modified "2023-10-15" @default.
• W4385330511 title "Association of malignant ascites with systemic inflammation and muscle loss after treatment in advanced‐stage ovarian cancer" @default.
• W4385330511 cites W1913776872 @default.
• W4385330511 cites W1995031937 @default.
• W4385330511 cites W2002187071 @default.
• W4385330511 cites W2029321962 @default.
• W4385330511 cites W2101398993 @default.
• W4385330511 cites W2137226085 @default.
• W4385330511 cites W2145280166 @default.
• W4385330511 cites W2312081744 @default.
• W4385330511 cites W2407777719 @default.
• W4385330511 cites W2529245535 @default.
• W4385330511 cites W2539910027 @default.
• W4385330511 cites W2575793504 @default.
• W4385330511 cites W2736112965 @default.
• W4385330511 cites W2743199111 @default.
• W4385330511 cites W2749051847 @default.
• W4385330511 cites W2807649309 @default.
• W4385330511 cites W2884193995 @default.
• W4385330511 cites W2886482717 @default.
• W4385330511 cites W2891012290 @default.
• W4385330511 cites W2922513541 @default.
• W4385330511 cites W2946398392 @default.
• W4385330511 cites W2964691037 @default.
• W4385330511 cites W2986246698 @default.
• W4385330511 cites W2993382907 @default.
• W4385330511 cites W3000072669 @default.
• W4385330511 cites W3003994673 @default.
• W4385330511 cites W3011737478 @default.
• W4385330511 cites W3092412842 @default.
• W4385330511 cites W3095418937 @default.
• W4385330511 cites W3095467275 @default.
• W4385330511 cites W3095608374 @default.
• W4385330511 cites W3136000048 @default.
• W4385330511 cites W3164402447 @default.
• W4385330511 cites W3190087412 @default.
• W4385330511 cites W3194600479 @default.
• W4385330511 cites W4200132179 @default.
• W4385330511 cites W4200253304 @default.
• W4385330511 cites W4200379278 @default.
• W4385330511 cites W4206479761 @default.
• W4385330511 cites W4206841660 @default.
• W4385330511 cites W4210962013 @default.
• W4385330511 cites W4211216570 @default.
• W4385330511 cites W4223586115 @default.
• W4385330511 cites W4224312175 @default.
• W4385330511 cites W4281806256 @default.
• W4385330511 cites W4294751357 @default.
• W4385330511 cites W4385330511 @default.
• W4385330511 doi "https://doi.org/10.1002/jcsm.13289" @default.
• W4385330511 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37503876" @default.
• W4385330511 hasPublicationYear "2023" @default.
• W4385330511 type Work @default.
• W4385330511 citedByCount "0" @default.
• W4385330511 crossrefType "journal-article" @default.
• W4385330511 hasAuthorship W4385330511A5005935812 @default.
• W4385330511 hasAuthorship W4385330511A5006613898 @default.
• W4385330511 hasAuthorship W4385330511A5008775517 @default.
• W4385330511 hasAuthorship W4385330511A5013682306 @default.
• W4385330511 hasAuthorship W4385330511A5037997481 @default.
• W4385330511 hasAuthorship W4385330511A5082840873 @default.
• W4385330511 hasBestOaLocation W43853305111 @default.
• W4385330511 hasConcept C121608353 @default.
• W4385330511 hasConcept C126322002 @default.
• W4385330511 hasConcept C143998085 @default.
• W4385330511 hasConcept C146357865 @default.
• W4385330511 hasConcept C151730666 @default.
• W4385330511 hasConcept C2776252253 @default.
• W4385330511 hasConcept C2776914184 @default.
• W4385330511 hasConcept C2777761686 @default.
• W4385330511 hasConcept C2778963024 @default.
• W4385330511 hasConcept C2780427987 @default.
• W4385330511 hasConcept C2780496750 @default.
• W4385330511 hasConcept C2781100745 @default.
• W4385330511 hasConcept C71924100 @default.
• W4385330511 hasConcept C86803240 @default.
• W4385330511 hasConcept C90924648 @default.
• W4385330511 hasConceptScore W4385330511C121608353 @default.
• W4385330511 hasConceptScore W4385330511C126322002 @default.
• W4385330511 hasConceptScore W4385330511C143998085 @default.
• W4385330511 hasConceptScore W4385330511C146357865 @default.
• W4385330511 hasConceptScore W4385330511C151730666 @default.
• W4385330511 hasConceptScore W4385330511C2776252253 @default.
• W4385330511 hasConceptScore W4385330511C2776914184 @default.
• W4385330511 hasConceptScore W4385330511C2777761686 @default.
• W4385330511 hasConceptScore W4385330511C2778963024 @default.
• W4385330511 hasConceptScore W4385330511C2780427987 @default.
• W4385330511 hasConceptScore W4385330511C2780496750 @default.
• W4385330511 hasConceptScore W4385330511C2781100745 @default.
• W4385330511 hasConceptScore W4385330511C71924100 @default.
• W4385330511 hasConceptScore W4385330511C86803240 @default.

• next